This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Institute for Research in Biomedicine, The Pirbright Institute, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2021.
Company Filing History:
1 out of 76 
1 out of 15 
1 out of 3,690 
Years Active: 2021
Title: Geraldine Taylor: Innovator in Respiratory Syncytial Virus Research
Introduction
Geraldine Taylor is a prominent inventor based in Berkshire, GB. She has made significant contributions to the field of immunology, particularly in the development of vaccines against respiratory viruses. Her innovative work has led to the creation of a patent that addresses critical health challenges.
Latest Patents
Geraldine Taylor holds a patent for "Recombinant prefusion RSV F proteins and uses thereof." This invention provides immunogens comprising a recombinant Respiratory Syncytial Virus (RSV) F protein stabilized in a prefusion conformation, along with nucleic acids encoding such immunogens. The patent outlines polypeptides, polynucleotides, and compositions designed to elicit an immune response to bovine respiratory syncytial virus (bRSV). Additionally, it describes methods for generating an immune response in a subject, including treatments for preventing RSV infections through the administration of a therapeutically effective amount of the antigen.
Career Highlights
Throughout her career, Geraldine has worked with esteemed organizations such as The Pirbright Institute and the Institute for Research in Biomedicine. Her research has focused on developing effective immunological responses to viral infections, showcasing her dedication to advancing public health.
Collaborations
Geraldine has collaborated with notable colleagues, including Lei Chen and Baoshan Zhang. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Geraldine Taylor's work in the field of respiratory virus research exemplifies her commitment to innovation and public health. Her patent on recombinant RSV F proteins highlights her significant contributions to immunology and the potential for improved treatments against viral infections.